Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation

Journal of Clinical Virology

Volumn 45, Issue 1, 2009, Pages 47-53

  Engelmann, Ilka ^a   Welte, Tobias ^a   Fühner, Thomas ^a   Simon, Andre R ^a   Mattner, Frauke ^a,b   Hoy, Ludwig ^a   Schulz, Thomas F ^a   Gottlieb, Jens ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Bronchiolitis obliterans; Cohort study; Cytomegalovirus; Human herpesvirus 4; Lung transplantation; Polymerase chain reaction

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PP65 ANTIGEN; PREDNISOLONE; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG; VALGANCICLOVIR; VINCRISTINE; VIRUS ANTIGEN; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS; COHORT ANALYSIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DNA DETERMINATION; EPSTEIN BARR VIRUS; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN ADENOVIRUS; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETRANSPLANTATION; RISK FACTOR; VIRUS DETECTION; VIRUS INFECTION; VIRUS REACTIVATION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; AGED; BRONCHIOLITIS OBLITERANS; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; VIRAL MATRIX PROTEINS;

EID: 67349265613     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.02.005     Document Type: Article

References (32)

1. Nicod L.P. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 3 (2006) 444-449
2. Sharples L.D., McNeil K., Stewart S., and Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 21 (2002) 271-281
3. Husain S., and Singh N. Bronchiolitis obliterans and lung transplantation: evidence for an infectious etiology. Semin Respir Infect 17 (2002) 310-314
4. Estenne M., Maurer J.R., Boehler A., Egan J.J., Frost A., Hertz M., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
5. Ison M.G. Adenovirus infections in transplant recipients. Clin Infect Dis 43 (2006) 331-339
6. Avery R.K. Infections after lung transplantation. Semin Respir Crit Care Med 27 (2006) 544-551
7. Fishman J.A., Emery V., Freeman R., Pascual M., Rostaing L., Schlitt H.J., et al. Cytomegalovirus in transplantation-challenging the status quo. Clin Transplant 21 (2007) 149-158
8. Zamora M.R. Cytomegalovirus and lung transplantation. Am J Transplant 4 (2004) 1219-1226
9. Bakker N.A., van Imhoff G.W., Verschuuren E.A., and van Son W.J. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transplant Int 20 (2007) 207-218
10. Snell G.I., Boehler A., Glanville A.R., McNeil K., Scott J.P., Studer S.M., et al. Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation. J Heart Lung Transplant 26 (2007) 423-430
11. Heim A., Ebnet C., Harste G., and Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 70 (2003) 228-239
12. Engelmann I., Petzold D.R., Kosinska A., Hepkema B.G., Schulz T.F., and Heim A. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens. J Med Virol 80 (2008) 467-477
13. Ahya V.N., Douglas L.P., Andreadis C., Arnoldi S., Svoboda J., Kotloff R.M., et al. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection. J Heart Lung Transplant 26 (2007) 839-844
14. Haque T., Thomas J.A., Parratt R., Hunt B.J., Yacoub M.H., and Crawford D.H. A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. Transplantation 64 (1997) 1028-1034
15. Bakker N.A., Verschuuren E.A., Erasmus M.E., Hepkema B.G., Veeger N.J., Kallenberg C.G., et al. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression. Transplantation 83 (2007) 433-438
16. Humar A., Kumar D., Mazzulli T., Razonable R.R., Moussa G., Paya C.V., et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant 5 (2005) 2555-2559
17. Westall G.P., Michaelides A., Williams T.J., Snell G.I., and Kotsimbos T.C. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 75 (2003) 2064-2068
18. Neurohr C., Huppmann P., Leuchte H., Schwaiblmair M., Bittmann I., Jaeger G., et al. Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome?. Am J Transplant 5 (2005) 2982-2991
19. Klein S.C., Kube D., Abts H., Diehl V., and Tesch H. Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection. Leuk Res 20 (1996) 633-636
20. Yoshimoto T., Nagase H., Yoneto T., Inoue J., and Nariuchi H. Interleukin-12 expression in B cells by transformation with Epstein-Barr virus. Biochem Biophys Res Commun 252 (1998) 556-560
21. Uchihara J.N., Krensky A.M., Matsuda T., Kawakami H., Okudaira T., Masuda M., et al. Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1. Int J Cancer 114 (2005) 747-755
22. Yu J.S., Tsai H.C., Wu C.C., Weng L.P., Li H.P., Chung P.J., et al. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation. Oncogene 21 (2002) 8047-8061
23. Buettner M., Meyer B., Schreck S., and Niedobitek G. Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40. Int J Cancer 121 (2007) 2703-2710
24. Reynaud-Gaubert M., Marin V., Thirion X., Farnarier C., Thomas P., Badier M., et al. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant 21 (2002) 721-730
25. Meloni F., Vitulo P., Cascina A., Oggionni T., Bulgheroni A., Paschetto E., et al. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome. J Heart Lung Transplant 23 (2004) 1053-1060
26. Gabbay E., Walters E.H., Orsida B., Whitford H., Ward C., Kotsimbos T.C., et al. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am J Respir Crit Care Med 162 (2000) 2182-2187
27. Danziger-Isakov L.A., DelaMorena M., Hayashi R.J., Sweet S., Mendeloff E., Schootman M., et al. Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients. Transplantation 75 (2003) 1538-1543
28. Belperio J.A., Lake K., Tazelaar H., Keane M.P., Strieter R.M., and Lynch III J.P. Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation. Semin Respir Crit Care Med 24 (2003) 499-530
29. Khalifah A.P., Hachem R.R., Chakinala M.M., Schechtman K.B., Patterson G.A., Schuster D.P., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am. J. Respir. Crit Care Med. 170 (2004) 181-187
30. Billings J.L., Hertz M.I., Savik K., and Wendt C.H. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 21 (2002) 559-566
31. Kumar D., Erdman D., Keshavjee S., Peret T., Tellier R., Hadjiliadis D., et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 5 (2005) 2031-2036
32. Milstone A.P., Brumble L.M., Barnes J., Estes W., Loyd J.E., Pierson III R.N., et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 28 (2006) 131-137